Jim Zhong
Overview
Jim Zhong, MD, is a board certified radiation oncologist specializing in the treatment of central nervous system malignancies, including brain and spine tumors, and head and neck cancer. He treats patients at Winship Cancer Institute's Clifton campus and Emory Proton Therapy Center.
Dr. Zhong graduated summa cum laude from Emory University, where he earned a BS in biology with highest honors. He subsequently completed medical school at Duke University School of Medicine in Durham, NC. After medical school, Dr. Zhong returned to his home city of Atlanta, GA to complete his Radiation Oncology Residency at Emory University. He was selected to serve as chief resident during his final year of residency training.
Dr. Zhong's research interest focuses on optimizing treatment outcomes for patients with malignant brain tumors, including glioblastomas, as well as the multidisciplinary management of brain metastases. He is currently the principal investigator of a study which seeks to evaluate treatment efficacy with focus on maximizing the quality of life in patients with brain metastases. He is a member of multiple professional organizations including the Society for Neuro-Oncology, the American Society for Radiation Oncology, and the American Society of Clinical Oncology.
During his training, Dr. Zhong earned several honors including the 2017 American Society of Clinical Oncology (ASCO) Conquer Foundation Merit Award and the Roentgen Resident/Fellow Research Award. He also received the honors of Phi Beta Kappa and the Barry M. Goldwater honorable mention during his attendance at Emory University.
Dr. Zhong has published and co-authored multiple manuscripts published in oncology journals such as Cancer, Neurosurgery, International Journal of Radiation Oncology, Biology, Physics, and Radiotherapy and Oncology.
Academic Appointment
- Associate Professor, Department of Radiation Oncology, Emory University School of Medicine
Education
Degrees
- MD from Duke University
Research
Publications
-
Immune niches in brain metastases contain TCF1+ stem-like T cells, are associated with disease control and are modulated by preoperative SRS.
Res Sq
03/23/2023 Authors: Jansen CS; Prabhu RS; Pagadala MS; Chappa P; Goyal S; Zhou C; Neill SG; Prokhnevska N; Cardenas M; Hoang KB -
Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy.
Radiother Oncol Volume: 175 Page(s): 93 - 100
10/01/2022 Authors: Qian DC; Marascio JA; Tobillo R; Lorenz JW; McCall NS; Neill SG; Hoang KB; Olson JJ; Eaton BR; Shu H-KG -
Modern Linear Accelerator-Based Radiotherapy Is Safe and Effective in the Treatment of Secretory and Nonsecretory Pituitary Adenomas.
World Neurosurg Volume: 160 Page(s): e33 - e39
04/01/2022 Authors: Janopaul-Naylor JR; Rupji M; Zhong J; Eaton BR; Ali N; Ioachimescu AG; Oyesiku NM; Shu H-KG -
Impact of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma (the MEMOIR study): A propensity score-matched analysis
Volume: 33 Page(s): S12 - S12
03/08/2022 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM -
Radiation Therapy for IDH-Mutant Grade 2 and Grade 3 Diffuse Glioma: An ASTRO Clinical Practice Guideline.
Pract Radiat Oncol Volume: 12 Page(s): 370 - 386
01/01/2022 Authors: Halasz LM; Attia A; Bradfield L; Brat DJ; Kirkpatrick JP; Laack NN; Lalani N; Lebow ES; Liu AK; Niemeier HM -
A multi-institutional pilot clinical trial of spectroscopic MRI-guided radiation dose escalation for newly diagnosed glioblastoma.
Neurooncol Adv Volume: 4 Page(s): vdac006
01/01/2022 Authors: Ramesh K; Mellon EA; Gurbani SS; Weinberg BD; Schreibmann E; Sheriff SA; Goryawala M; de le Fuente M; Eaton BR; Zhong J -
Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
Lancet Oncol Volume: 22 Page(s): 1777 - 1786
12/01/2021 Authors: Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM -
TREATMENT TRENDS AND SURVIVAL OUTCOMES IN ATYPICAL MENINGIOMA
Volume: 23 Page(s): 48 - 48
11/01/2021 Authors: Syed Y; Rupji M; Switchenko J; Eaton B; Olson J; Kimberly H; Bray D; Shu H-K; Zhong J -
Surgical Outcomes of Novel Collagen Tile Cesium Brachytherapy for Recurrent Intracranial Tumors at a Tertiary Referral Center.
Cureus Volume: 13 Page(s): e19777
11/01/2021 Authors: Warren KT; Boucher A; Bray DP; Dresser S; Zhong J; Shu H-K; Olson J; Hoang K -
Phase I Dose Escalation Trial of Hypofractionated Radiosurgery for Large Intact or Resected Brain Metastases
Volume: 111 Page(s): S25 - S25
11/01/2021 Authors: Eaton BR; Chen Z; Butker EK; Gorgens U; Zhong J; Higgins KA; Patel PR; Bradley JD; Hoang KB; Nduom E